FDA Approved: ALVESCO — Supplemental Application (Covis Pharma US, Inc)

View source ↗

Summary

FDA approved a supplemental application for ALVESCO (ciclesonide) from Covis Pharma US, Inc., resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Alvesco (ciclesonide)

Snippet

SUPPL AP for ALVESCO (CICLESONIDE)